A Depakote birth defect lawsuit accuses Abbott Laboratories and AbbVie of failing to warn pregnant mothers and the medical community of the risk of malformations and cognitive defects associated with…
Thousands of pregnant French women took Depakote, the anti-epilepsy drug, from 2007 to 2014, despite known risks of birth malformations, according to an upcoming study.
A jury has awarded $15 million to a 12-year-old who was born with birth defects after her mother used Depakote during pregnancy.
European health officials are calling for restrictions and more education on the risk of Depakote birth defects.
Depakote was associated with decreased language and motor control skills when compared to Keppra and children not exposed to epilepsy drugs in the womb, according to new research.
Abbott has been ordered to turn over Depakote birth defect documents by a federal judge who accuses the company of dragging its feet.
A federal judge has approved an investor Depakote class action lawsuit by stockholders who say the company illegally marketed the epilepsy drug.
Abbott Laboratories faces a product liability lawsuit brought by a California woman who indicates that she gave birth to three children who suffered birth defects and congenital malformations that were…
According to a new warning issued by federal drug regulators, pregnant women should not use certain epilepsy drugs to treat migraines, due to a potential risk that drugs like Depakote…
Danish researchers have released a new study that adds to the mounting evidence linking the use of Depakote and autism among children exposed to the medication during pregnancy.
